1. Home
  2. EVLV vs BCRX Comparison

EVLV vs BCRX Comparison

Compare EVLV & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVLV
  • BCRX
  • Stock Information
  • Founded
  • EVLV 2013
  • BCRX 1986
  • Country
  • EVLV United States
  • BCRX United States
  • Employees
  • EVLV N/A
  • BCRX N/A
  • Industry
  • EVLV Computer peripheral equipment
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EVLV Technology
  • BCRX Health Care
  • Exchange
  • EVLV Nasdaq
  • BCRX Nasdaq
  • Market Cap
  • EVLV 1.4B
  • BCRX 1.4B
  • IPO Year
  • EVLV N/A
  • BCRX 1994
  • Fundamental
  • Price
  • EVLV $8.28
  • BCRX $7.21
  • Analyst Decision
  • EVLV Strong Buy
  • BCRX Strong Buy
  • Analyst Count
  • EVLV 4
  • BCRX 11
  • Target Price
  • EVLV $8.88
  • BCRX $19.55
  • AVG Volume (30 Days)
  • EVLV 2.5M
  • BCRX 6.8M
  • Earning Date
  • EVLV 11-13-2025
  • BCRX 11-03-2025
  • Dividend Yield
  • EVLV N/A
  • BCRX N/A
  • EPS Growth
  • EVLV N/A
  • BCRX N/A
  • EPS
  • EVLV N/A
  • BCRX N/A
  • Revenue
  • EVLV $121,011,000.00
  • BCRX $557,506,000.00
  • Revenue This Year
  • EVLV $31.07
  • BCRX $41.40
  • Revenue Next Year
  • EVLV $17.67
  • BCRX $5.33
  • P/E Ratio
  • EVLV N/A
  • BCRX N/A
  • Revenue Growth
  • EVLV 36.64
  • BCRX 45.85
  • 52 Week Low
  • EVLV $2.04
  • BCRX $6.00
  • 52 Week High
  • EVLV $8.91
  • BCRX $11.31
  • Technical
  • Relative Strength Index (RSI)
  • EVLV 56.91
  • BCRX 47.92
  • Support Level
  • EVLV $7.61
  • BCRX $6.44
  • Resistance Level
  • EVLV $8.31
  • BCRX $6.92
  • Average True Range (ATR)
  • EVLV 0.43
  • BCRX 0.31
  • MACD
  • EVLV 0.00
  • BCRX 0.07
  • Stochastic Oscillator
  • EVLV 64.51
  • BCRX 88.43

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: